Medicine & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alcon, Inc.
Alcon gets U.S. FDA approval for Ladar6000 Excimer Laser, Wavefront-Guided Hyperopia
June 2nd, 2006
Alcon, Inc., (ACL) announced that the U.S. Food & Drug Administration (FDA) has approved its Ladar6000 Excimer Laser with high speed ablation for use in Lasik and PRK refractive surgery. With a 50% faster ablation rate than previous Ladarvision platforms, the Ladar6000 laser significantly decreases surgical time, especially in higher refractive correction ranges, and results in less exposure of the corneal flap. The Ladar6000 laser, developed on a flexible platform to allow for future upgrades, also includes a number of enhancements that are designed to improve overall system performance, ease of use, and patient flow. The FDA...
Source: Medicine & Law Weekly (2006-06-02)
|
